MAR vs TMO: Which Is the Better Buy?
Side-by-side comparison of Marriott International, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Marriott International, Inc. · Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction
Grade C
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MAR |
TMO |
| Current Price |
$334.97 |
$658.32 |
| Fair Value Estimate |
$403.81 |
$863.34 |
| Upside to Fair Value |
+20.6%
|
+31.1%
|
| Market Cap |
$87.3B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
22.2x
|
25.9x
|
| Price / Sales |
3.2x
|
5.3x
|
| Price / FCF |
28.7x
|
33.4x
|
| Revenue Growth YoY |
+4.8%
|
+10.5%
|
| Gross Margin |
20.2%
|
40.4%
|
| Operating Margin |
15.8%
|
17.7%
|
| Return on Equity |
-66.7%
|
13.4%
|
| Dividend Yield |
0.84% |
0.28% |
| FCF Yield |
3.48%
|
3.0%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
MAR |
TMO |
| Zone Low |
$302.86 |
$647.50 |
| Zone High |
$343.24 |
$733.84 |
| In Buy Zone? |
Yes
|
Yes
|